|
Unreadable document.
|
1969 |
AR226-1969
|
99jwyVrXdeO3VnLjO5kYpRGop |
4 |
|
Unreadable document.
|
1968 |
AR226-1968
|
vy692dyO8LO3Za2wZnR3zZnzZ |
4 |
|
The document details an acute toxicity test on a mixture containing perfluorooctanesulfonate (PFOS) using eastern oysters (Crassostrea virginica), indicating that the test sample, identified as FC-206, consists of 0.67% PFOS among other components, and outlines the methodology and conditions of the bioassay conducted.
|
1967 |
AR226-0786
|
g2Rq3d7zqEZ8Edqoz1JDOjxX3 |
8 |
|
Unreadable document.
|
1967 |
AR226-1967
|
rp8yzXRw6YaozZvj0Q1y4nJNr |
3 |
|
The document details an acute toxicity test of a mixture containing perfluorooctanesulfonate (PFOS) on eastern oyster embryos (Crassostrea virginica), using a Pacific Oyster Bioassay method to assess the impact of the test substance, identified as FC-206, which comprises 0.67% PFOS among other components.
|
1967 |
AR226-0786
|
1Qka5x2JOdBryvnkmvekz54Ya |
8 |
|
The document outlines the status and program related to C-8 (PFOS) control at DuPont, including communication meetings, epidemiology studies, and findings indicating no conclusive evidence of health problems among workers exposed to C-8.
|
1965 |
AR226-1965
|
MGNDo4NQ6Qx3zdRjzN0BZX2yL |
36 |
|
The document reports that a skin irritation and sensitization study conducted by Haskell Laboratory on fabrics treated with a proposed fabric softener, which contained PFOA, showed no adverse reactions in 204 subjects, indicating that the commercial use of the softener would not cause contact dermatitis.
|
1965 |
AR226-2823
|
LKeYy4vmbg0pD2y0QX6N5mjk5 |
1 |
|
This document outlines a 90-day feeding study on a compound sponsored by E. I. duPont de Nemours and Company, detailing methods and results related to the health effects observed in Beagle dogs.
|
1965 |
AR226-2825
|
aBzQ2073wexjZ3Dy1vrGNQ9M |
57 |
|
The document reports on a 90-day feeding study conducted by the International Research and Development Corporation, sponsored by E.I. duPont de Nemours and Company, which found no adverse effects on body weight gain or significant hematologic and biochemical changes in rats fed diets containing varying levels of a perfluorinated compound.
|
1965 |
AR226-2824
|
2RxxLkQerxGkem1Bjkam7gV4R |
90 |
|
The document outlines a protocol for an exploratory in-vitro absorption study of perfluorooctylsulfonate (PFOS) and ammonium perfluorooctanoate (PFOA) using the SkinEthic Reconstituted Epidermis Model, conducted by 3M's Corporate Toxicology Department.
|
1962 |
AR226-0182
|
gb6gRG7rzy2oY2nQ2OXLVem3V |
6 |
|
The document outlines a protocol for an exploratory in-vitro absorption study of perfluorooctylsulfonate and ammonium perfluorooctanoate, conducted by 3M's Corporate Toxicology Department to assess skin absorption using the SkinEthic Reconstituted Epidermis Model.
|
1962 |
AR226-0182
|
pBqGoy0rwZnLZJpoKwoOR1oBX |
6 |
|
This document reports on a study conducted by 3M to investigate the mechanism of toxicity of Perfluorooctanesulfonate (PFOS) in adult rats, focusing on its potential to damage muscle mitochondria and cause conditions like rhabdomyolysis and lactic acidosis at high exposure levels.
|
1962 |
AR226-1724
|
ppyoKX7VOMZa2MdjgJ9q539mj |
14 |
|
The document reports on a study conducted by 3M to investigate the mechanism of toxicity in adult rats exposed to high levels of Perfluorooctanesulfonate (PFOS), specifically examining its potential to damage muscle mitochondria and lead to conditions like rhabdomyolysis and lactic acidosis.
|
1962 |
AR226-1781
|
jJyxDK8kbzpjmw2BXbYx51v9 |
14 |
|
The document discusses the covariant analysis for study 418-020 related to sexual maturation in rats exposed to a test substance, with a focus on how gestational age and body weight affect maturation outcomes, potentially relevant for understanding the effects of PFOA or PFOS.
|
1962 |
AR226-1781
|
6w4bE9nXz0OEEN0mgVV6qxRa3 |
22 |
|
A retrospective cohort mortality study conducted by University of Minnesota epidemiologists on 3M employees at the Decatur, Alabama plant found no significantly elevated standardized mortality ratios (SMRs) for those exposed to perfluorinated compounds, with recommendations for an updated study to include additional mortality data.
|
1961 |
AR226-0032
|
EqDBZrpLYDGrpqO2x6azbY8Eg |
50 |
|
A mortality study of employees at the 3M plant in Decatur, Alabama, conducted by University of Minnesota epidemiologists, found no significantly elevated standardized mortality ratios (SMRs) among workers exposed to perfluorinated compounds, with recommendations for an updated study to include additional mortality data.
|
1961 |
AR226-0032
|
LKDKn5EdLgvnxXwmB6r74Mj5 |
50 |
|
The document is a letter from 3M's Dr. William Weppner to EPA's Charles M. Auer, outlining the agenda for a meeting on December 14, 1998, to discuss the TSCA 8(e) filing regarding the presence of perfluorooctane sulfonate (PFOS) in blood samples from the general population.
|
1958 |
AR226-0622
|
qaOX6wYVmkkDp14DN5banDY5M |
1 |
|
3M is submitting additional pathology reviews related to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) to the EPA as part of their ongoing dialogue regarding perfluorochemicals.
|
1958 |
AR226-1915
|
dn00YymvDjERyQDg4ZrBBpgLR |
1 |
|
The document is a letter from 3M's Dr. William Weppner to EPA's Charles M. Auer, outlining the agenda for a meeting on December 14, 1998, to discuss the TSCA 8(e) filing regarding the presence of perfluorooctane sulfonate (PFOS) in blood samples from the general population.
|
1958 |
AR226-0622
|
NGNJa0Mvdb6pBq085nZYVp6qy |
1 |
|
3M submitted pharmacokinetic studies on perfluorobutane carboxylate (PFBA), perfluorooctane sulfonate (PFOS), and perfluorooctanoic acid (PFOA) to the EPA as part of their ongoing dialogue regarding perfluorochemicals.
|
1958 |
AR226-3925
|
pBxeKoO3X10Y562rM53JgxpeB |
2 |
|
This document reports on a study evaluating the incidence of myocardial infarction among male employees at the Washington Works Plant from 1956 to 1973, revealing 61 observed cases and comparing them to expected rates based on Du Pont Company statistics.
|
1956 |
AR226-1496
|
xz68NroLV7vakkEKny8GGazX0 |
8 |
|
This document is the final report of a case-control study investigating leukemia at the Washington Works site, sponsored by DuPont Co. and Polymer Products, with a focus on exposure assessment related to perfluorinated compounds.
|
1953 |
AR226-1308
|
82g4qR1grJGz1B3ddoGVmDNLy |
13 |
|
This document appears to be an emissions inventory report detailing surfactant emissions from various stacks, including their dimensions, flow rates, and temperatures, along with permitted and actual emissions data.
|
1953 |
AR226-2161
|
daMed2e0EQGLVq4jo7QB70K8q |
3 |
|
This document appears to be a detailed emissions report summarizing stack parameters, flow rates, and estimated emissions for various vents associated with a semiworks application, including specific measurements such as diameter, height, and temperature.
|
1953 |
AR226-2168
|
eNQkbDR2VEbQz4rNrvgR3mNy |
5 |
|
This document appears to be a detailed emissions report outlining stack specifications, flow rates, and permitted versus actual emissions for various units, including multiple stack identifiers and measurements for a facility's air emissions compliance.
|
1953 |
AR226-2170
|
zE84JYoXd6r5EaQR5kKxL3Dz |
1 |
|
This document appears to be an emissions inventory report detailing permitted and actual emissions for various stack vents, including specific measurements such as stack diameter, height, flow velocity, and temperature, along with associated particulate matter fractions.
|
1953 |
AR226-2176
|
rZd6QvJkjv3DERGdr6YwG8Zq |
3 |
|
This document appears to be a data sheet detailing stack emissions and surfactant rates for various vents, including actual and permitted emission levels, stack dimensions, and flow velocities, likely related to a semiworks application.
|
1953 |
AR226-2200
|
nzgvOZr5m4QpbKMzL44Zbjq1 |
2 |
|
This document appears to be a data report detailing emissions and operational parameters for various permit vent IDs, including stack dimensions, flow velocities, and estimated emissions for a semiworks application.
|
1953 |
AR226-2213
|
G6V91NmBXJ39OVwO27vrJ1oMV |
4 |
|
This document contains emission data and parameters related to a permit application (Permit Number 1881253DA) for a facility with multiple vent IDs, detailing flow rates, velocities, and potential emissions.
|
1953 |
AR226-2222
|
QjEReVxd5jw9o9eaeOVnd798 |
5 |
|
The document provides production and emission data for perfluorinated compounds, specifically detailing annual production figures and emission rates from various sources in 2003, with a total emission of 11,154,000 pounds.
|
1953 |
AR226-2261
|
x1216aM715az0OOOzE347GRv1 |
2 |
|
This document includes various permit and emission data related to stack emissions for multiple units, with specific reference to surfactant rates and particulate emissions as part of an Air Emissions Inventory.
|
1953 |
AR226-2298
|
9kZp3NRMOpw6EZnR0drgeQw7 |
7 |
|
This document contains emissions data and permit information for various vents associated with a semiworks application, detailing stack dimensions, flow rates, and emission rates for specific substances.
|
1953 |
AR226-2299
|
2RMQEk2axb711zkXb0Ox2ak2g |
5 |
|
This document appears to be a series of laboratory data entries related to air quality measurements, specifically focusing on PFOA levels over several years, but the content is largely obscured and difficult to interpret.
|
1950 |
AR226-2002
|
XRmGqjDDXvmo66X3LM1Nbk5Od |
11 |
|
The document provides background information on ammonium perfluorooctanoate (C-8), detailing its use as a dispersing agent in polymerization for Teflon and other fluoropolymers, its environmental release pathways, and contamination findings at the Washington Works site, including groundwater and soil contamination.
|
1950 |
AR226-2412
|
6R3DOZzKrKyrdo9xXYrLJk3Mo |
9 |
|
The document outlines Dupont Fluoroproducts' history of using Ammonium Perfluorooctanoate (C-8) since the 1950s, detailing storage, handling practices, a past spill incident, and the company's commitment to reducing C-8 emissions to very low levels.
|
1950 |
AR226-2470
|
a4n8B0M0kBp2Eyj5v2RK1ej2b |
2 |
|
The document reports on a retrospective cohort mortality study of employees at the Chemolite Plant in Cottage Grove, Minnesota, conducted by Schuman and Mandel, which found no significant mortality findings related to perfluorooctanoic acid (PFOA) among the 3,688 workers studied, and recommends continued monitoring of the cohort's vital status.
|
1947 |
AR226-0470
|
ppRGXZEbK5z7DVydvq8YQy4mj |
16 |
|
The document reports on a retrospective cohort mortality study of employees at the Chemolite Plant in Cottage Grove, Minnesota, conducted by Schuman and Mandel, which found no significant mortality findings related to perfluorooctanoic acid (PFOA) among the 3,688 workers studied.
|
1947 |
AR226-0470
|
85xGDjrE63bjXM5jq6oEwr1Ek |
16 |
|
The document is a final report detailing an extended laboratory study on the atmospheric degradation of the fluorinated alcohol C6F13CH2CH2OH and its aldehyde product C6F13CHO, conducted by CNRS-LCSR and RAND Corporation, which aims to understand the photolysis rates and environmental impact of these compounds.
|
1944 |
AR226-1944
|
DD2GGqg5EbGBNOOker1GoBwqQ |
16 |
|
The document details an extended laboratory study conducted by Professor Georges Le Bras and colleagues on the photolysis rate of perfluorinated aldehydes, aiming to reduce or eliminate the production of corresponding perfluorocarboxylic acids under low NOx conditions, using solar radiation experiments at the EUPHORE facility in Valencia, Spain.
|
1943 |
AR226-1943
|
9Jne4dBoXG5znjRqzpEZxdZ17 |
7 |
|
The document is a submission from the Telomer Research Program, representing companies including DuPont, to the EPA, providing a final report and study summary on the atmospheric degradation of fluorinated alcohols, which is related to PFOA and PFOS research.
|
1942 |
AR226-1942
|
VembBGezvKLGpjo5EK1qjEEq |
1 |
|
the maternal toxicity observed at 500 mg/kg/day of 8-2 Telomer B Alcohol, as indicated by maternal mortality, decreased body weights, and increased clinical toxicity signs in the study conducted by E.I. du Pont de Nemours and Company.
|
1940 |
AR226-1940
|
KRogqqVRe7x7511Vvkz6BDyp0 |
15 |
|
The document reports on a developmental toxicity study of 8-2 Telomer B Alcohol conducted by DuPont, following EPA and OECD guidelines, to assess its effects on rats.
|
1939 |
AR226-1939
|
gDorZ88LEeEgoGrE13Vx1NmGN |
156 |
|
The document is an analytical report from Severn Trent Laboratories for Weston Solutions, Inc. regarding a confidential investigation in Decatur, detailing wet chemistry data and sample analysis related to perfluorinated compounds.
|
1938 |
—
|
91QQGGzKweLzEB38ow2w1VeB6 |
90 |
|
The document is an analytical report from Severn Trent Laboratories for Weston Solutions, Inc. regarding a confidential investigation in Decatur, which includes wet chemistry data and sample information related to perfluorinated compounds.
|
1938 |
AR226-3828
|
V3kx1Z7E48r5OyqoxxBj4dvyj |
90 |
|
The document reports that a primary skin irritation test conducted on T-3493 at Riker Laboratories, Inc. found it to be non-irritating to the skin of female albino rabbits, with no signs of erythema or edema observed.
|
1934 |
AR226-0305
|
3JK5JwZDgeJNkEN3G91Oxky20 |
10 |
|
The document reports that a primary skin irritation test conducted on T-3493 at Riker Laboratories, Inc. found it to be non-irritating to the skin of female albino rabbits, with no signs of erythema or edema observed.
|
1934 |
AR226-0305
|
jBrBZao8qa6B5RbMKEEzaoGJy |
10 |
|
This document is a revised analytical report from Exygen Research detailing the analysis of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS) in water samples from Oakdale Municipality, requested by Gary A. Rohenstein of 3M Company, with no changes to the analytical results.
|
1933 |
AR226-1933
|
o9r15jKYbJY4wzBDqb8mOpawo |
10 |
|
The document provides emission information and potential-to-emit calculations for various vents associated with semiworks applications, specifically focusing on C-8 (which includes perfluorinated compounds like PFOA) and detailing the expected distribution and particulate emissions from the sampling apparatus.
|
1933 |
AR226-2226
|
5Dy6J8EKdjE3bpJeqgo2VajV4 |
4 |
|
This document reports the analysis of blood samples for perfluorooctanoate (PFOA) conducted by DuPont, detailing the concentrations found in various samples collected in December 1981.
|
1932 |
AR226-1611
|
06RjE1Zm4aGpggeMDV7R5n2kJ |
3 |
|
This document appears to be a data report from an unspecified laboratory detailing analytical results, including concentration measurements and instrument conditions, related to a study conducted on March 19, 1995.
|
1932 |
AR226-2075
|
dYnNQe9BgXN5rXjZoLJByqBM5 |
2 |
|
The document is a study report by E. I. du Pont de Nemours and Company detailing a static acute 96-hour LC50 test of the substance H-19,173 on fathead minnows (Pimephales promelas), conducted under Good Laboratory Practice guidelines.
|
1932 |
AR226-2978
|
dgnn10MyeEKGM5NKygLDZ1eB |
14 |
|
The document is a response from XENOS regarding FDA inquiries about a toxicity study on the chemical F n -3 9 2 4 conducted by RIKER Laboratories, addressing liver changes in rats and confirming that the original findings remain unchanged despite the FDA's request for additional data.
|
1931 |
AR226-0263
|
8RB49MjNRdMYXQeDgaBj7mdrK |
11 |
|
The document discusses the response of XENOS to FDA inquiries regarding a toxicity study of the chemical F n-3 9 2 4 conducted by RIKER Laboratories, specifically addressing liver changes observed in rats and confirming that the original findings remain unchanged.
|
1931 |
AR226-0263
|
2ZBM0NV1GOgzM9Da82RDVvog |
11 |
|
The document reports on a study conducted by Riker Laboratories, a subsidiary of 3M, which found that cholestyramine treatment significantly enhanced the elimination of carbon-14 labeled FC-95 and FC-143 in male rats, reducing retention in liver, plasma, and red blood cells while increasing fecal excretion.
|
1930 |
AR226-0459
|
pBdB7ayjRQaEzXxNXEm3bj5qB |
29 |
|
The document reports that cholestyramine treatment significantly enhanced the elimination of carbon-14 labeled FC-95 and FC-143 in male rats, with notable reductions in liver, plasma, and red blood cell concentrations and increased fecal excretion compared to control groups.
|
1930 |
AR226-0459
|
5D24KMdnBNJx2rEQ0LoLLw7V |
29 |
|
The document is a correspondence from the Association of Plastics Manufacturers in Europe (APME) to the EPA, enclosing final reports on oral toxicity studies of ammonium perfluorooctanoate (APFO) in monkeys conducted by Covance Laboratories and analytical work by 3M, as part of the administrative record AR-226.
|
1928 |
AR226-1052
|
KJXYD3GnJqLa6R3xyzXODk57N |
2 |
|
The document reports the results of an acute toxicity test conducted by 3M Company on the perfluorinated compound Perfluorooctanesulfonylamido(ethyl)acetate (FC-109-X), finding a 96-hour LC50 value of 57 mg/L for fathead minnows (Pimephales promelas) and a no observed effect level of less than
|
1923 |
AR226-0396
|
XRK6rZYnNVRkYpZN3pqaD56GJ |
22 |
|
The document presents the results of an acute toxicity test on the perfluorinated compound Perfluorooctanesulfonylamido(ethyl)acetate (PFOSAA) conducted by 3M, indicating a 48-hour LC50 of 1.5 mg/L and a NOEL of 1.0 mg/L for the aquatic invertebrate Daphnia magna.
|
1923 |
AR226-0397
|
B5Q7ooRgwa4DJNO2p78j6brDk |
32 |
|
The document reports the results of an acute toxicity test conducted by 3M Company on the perfluorinated compound Perfluorooctanesulfonylamido(ethyl)acetate (FC-109-X), finding a 96-hour LC50 value of 57 mg/L for fathead minnows (Pimephales promelas) and a no observed effect level of less than
|
1923 |
AR226-0396
|
aJKanqZvLzEnk59YLVREQ03rb |
22 |
|
The document reports on an acute toxicity study of Perfluorooctanesulfonylamido(ethyl)acetate (PFOSAA) conducted by 3M Company, finding a 48-hour LC50 of 1.5 mg/L and a NOEL of 1.0 mg/L for the aquatic invertebrate Daphnia magna.
|
1923 |
AR226-0397
|
x1G0onkBQMg0jROy03qwnyz76 |
32 |
|
DuPont presented its comprehensive risk management strategy for PFOA to the EPA on January 31, 2005, emphasizing source reduction, voluntary commitments, and the need for open dialogue amid challenges related to safety perceptions and regulatory complexities.
|
1914 |
AR226-1914
|
vV41dpr5Gd6pDzDONwMGKbmjb |
43 |
|
This document appears to be a report discussing health concerns related to the use of a new formulation of Wilson Leather Protector, which has been associated with acute chemical pneumonia and hypersensitivity symptoms in individuals exposed to its fumes.
|
1913 |
AR226-3712
|
em2ZgLKVLqk34xnp32NZKGEqp |
2 |
|
The document outlines an ongoing occupational health study on PFOA involving 1,025 current workers at the DuPont Washington Works site, focusing on the relationship between serum PFOA levels and health outcomes through cross-sectional surveys and retrospective cohort mortality analyses.
|
1910 |
AR226-1910
|
O1Qw3KEzzgVqGDj3qbkv0VeQK |
13 |
|
The document summarizes the results of acute toxicity studies conducted by Hazleton Laboratories on T-l*101, a fluorochemical surfactant produced by 3M, indicating that it is slightly toxic when administered orally to rats and practically non-toxic via dermal exposure in rabbits.
|
1908 |
AR226-0979
|
N2ymR2VdZ9qGDdqkoXGg8Nvjb |
3 |
|
This document reports on a biodegradation test of Perfluorooctanesulfonylamido(ethyl)acetate (PFOSAA) conducted by 3M, indicating that while some biodegradation occurred, the results are inconclusive due to the mixture's composition and lack of detailed methodology.
|
1904 |
AR226-0404
|
LKeYLGyQb9XLZjq7J033Q6z53 |
14 |
|
The document reports on a biodegradation study of Perfluorooctanesulfonylamido(ethyl)acetate (PFOSAA) conducted by 3M, indicating a 90% mean DOC removal after 28 days, but concludes that no reliable conclusions can be drawn due to inaccuracies in the total organic carbon measurement.
|
1904 |
AR226-0405
|
p0Jgay0bgY2pqLLBJYrLgNJ6 |
15 |
|
The document reports on an acute toxicity test of a mixture identified as FC-129 (R1904) on fathead minnows, revealing an observed effect concentration of 54 mg/L.
|
1904 |
AR226-0406
|
kZEazBxw2xwObrMeJXQ1JVyJ |
18 |
|
The document reports on an acute toxicity test of a mixture containing perfluorooctanesulfonylamido(ethyl)acetate (PFOSAA) conducted on the aquatic plant Selenastrum capricornutum, revealing various EC50 values for cell count and average specific growth rate at different exposure times.
|
1904 |
AR226-0407
|
ev7vQXaOkanzw6V6aNgXOpvRq |
11 |
|
The document reports that the 3-hour EC50 for activated sludge respiration inhibition due to the perfluorinated compound Perfluorooctanesulfonylamido(ethyl)acetate (FC-129) was determined to be greater than 1000 mg/L, based on a mixture tested by 3M Company.
|
1904 |
AR226-0408
|
QXXOvOoQKk8wjvLVDE4kBkORo |
8 |
|
The document reports the results of a Microtox toxicity test on a mixture containing Perfluorooctanesulfonylamido(ethyl)acetate (PFOSAA), produced by 3M, indicating a 30-minute EC50 value of 274 mg/L for the test organism Vibrio fischeri.
|
1904 |
AR226-0409
|
GmjEbV0gmG4dGqJ3No61EErwv |
13 |
|
The document reports on a biodegradation test of Perfluorooctanesulfonylamido(ethyl)acetate (PFOSAA) conducted by 3M, indicating that while some biodegradation occurred in aerobic conditions, the results are inconclusive due to the test sample being a mixture and lacking detailed methodology.
|
1904 |
AR226-0404
|
3w8gvRj5rmqpXbJXkMeqvqdx |
14 |
|
The document reports on a biodegradation study of Perfluorooctanesulfonylamido(ethyl)acetate (PFOSAA) conducted by 3M, indicating a 90% mean DOC removal after 28 days, but concludes that no reliable conclusions can be drawn due to inaccuracies in the total organic carbon measurement and lack of characterization of the test substance.
|
1904 |
AR226-0405
|
Qkr28b8zYYJow4v4XL3xZmNbo |
15 |
|
The document reports on an acute toxicity test of a mixture referred to as FC-129 (R1904) on fathead minnows, indicating that the observed effect concentration was 54 mg/L.
|
1904 |
AR226-0406
|
bkNvkg4G984Y4gbLoweaGa83 |
18 |
|
The document reports on an acute toxicity test of a mixture containing perfluorooctanesulfonylamido(ethyl)acetate (PFOSAA) conducted on the aquatic plant Selenastrum capricornutum, revealing various EC50 values for cell count and average specific growth rate at different concentrations.
|
1904 |
AR226-0407
|
Y6y2NMyKQM174w7dnogXEMbV |
11 |
|
The document reports that the 3-hour EC50 for activated sludge respiration inhibition of the perfluorinated compound Perfluorooctanesulfonylamido(ethyl)acetate (PFOSAA) in a mixture from 3M was determined to be greater than 1000 mg/L, indicating no inhibition was observed.
|
1904 |
AR226-0408
|
k6Kk6Ry9mNzoBpgXy5OdOkDkB |
8 |
|
The document reports the results of a Microtox toxicity test on a mixture containing Perfluorooctanesulfonylamido(ethyl)acetate (PFOSAA), produced by 3M, indicating a 30-minute EC50 value of 274 mg/L for the test organism Vibrio fischeri.
|
1904 |
AR226-0409
|
bB4bEBmp3ovE90yXL126QQdr1 |
13 |
|
This is a figure from a monitoring program related to the Oakdale Disposal Site in Minnesota, depicting various well types and their locations in relation to the site.
|
1904 |
AR226-3638
|
M4pjKBDw6VqB1K5zXqrEwxDyV |
1 |
|
DuPont submitted corrected confidential business information (CBI) regarding polymeric products related to the Telomer Research Program, including CAS numbers and 2002 sales volumes, to the EPA as part of their commitment to provide data on perfluorinated compounds.
|
1903 |
AR226-1321
|
MGJX92bD4wYYpGjYEQ5qYBRZx |
2 |
|
This laboratory report from 3M Environmental Laboratory details a PFOS dietary LC50 study with mallard ducks, revealing that PFOS levels in the sera and livers of the ducks increased with dosage but declined significantly between days 8 and 22 post-exposure.
|
1902 |
AR226-1030
|
ev0j9NjzOqygjDN1G1D3Rn17q |
14 |
|
The document is a laboratory report from 3M Environmental Laboratory detailing a PFOS dietary LC50 study with mallard ducks, which found that PFOS levels in the sera and livers of the ducks increased with dose but declined significantly from day 8 to day 22 post-exposure.
|
1902 |
AR226-1030
|
nkXOj1rX3xeJvRvoYROjvD7v1 |
14 |
|
This laboratory report from 3M Environmental Laboratory details a PFOS dietary LC50 study with mallards, revealing that PFOS levels in the sera and livers of the ducks increased with dosage but declined significantly between days 8 and 22 post-exposure.
|
1902 |
AR226-1736
|
Z4LD4XgbZzRzyDbzZ3Ovbpjg7 |
14 |
|
This laboratory report from 3M Environmental Technology & Safety Services details a PFOS dietary LC50 study conducted on mallard ducks, revealing that PFOS levels in the sera and livers increased with dosage but declined significantly between days 8 and 22 post-exposure.
|
1902 |
AR226-1781
|
rex7w6mZm6oozdxgeQ9a2jQq7 |
14 |
|
The document is a laboratory report from 3M Environmental Technology & Safety Services detailing a PFOS dietary LC50 study with mallard ducks, which found that PFOS levels in the sera and livers of the ducks increased with dosage but declined significantly between days 8 and 22 post-exposure.
|
1902 |
AR226-1829
|
5kJqe1xYrOv6VbqNNnYbXyOvN |
14 |
|
The document is an analytical report from 3M Environmental Laboratory detailing a PFOS dietary LC50 study conducted on mallards, which includes serum and liver data with specific concentrations of PFOS measured in various samples.
|
1902 |
AR226-1853
|
o3Bkd4Q8QyrVB38E0N600p2D |
14 |
|
The TNO report details a study commissioned by 3M that investigates the effects of perfluorinated alkyl sulfonates (PFAS) on cholesterol and bile acid metabolism in ApoE3Leiden transgenic mice and rat hepatocytes.
|
1901 |
AR226-3763
|
50DBzMoQnmkg2OeY33yndkKwN |
35 |
|
The TNO report details a study commissioned by 3M that investigates the effects of perfluorinated alkyl sulfonates, specifically PFBS and PFHS, on cholesterol and bile acid metabolism in transgenic ApoE3Leiden mice and rat hepatocytes, highlighting significant metabolic alterations.
|
1901 |
AR226-3758
|
oez5Z7LZQ1bw82YyLB3Rxv22r |
207 |
|
DuPont submitted information to the EPA's Office of Pollution Prevention and Toxics regarding perfluorinated chemicals, including a precautionary TSCA 8(e) submission despite believing it did not trigger reporting obligations.
|
1900 |
AR226-1964
|
JNz64BdrwQYB9qG000KB7prKX |
43 |
|
The document reports that a study conducted by E. I. du Pont de Nemours and Company determined the LD50 of an unspecified substance, likely a perfluorinated compound, to be 1900 mg/kg in male rats, indicating it is slightly toxic when administered as a single oral dose.
|
1900 |
AR226-2921
|
ba7yL9mzyV3kv12OO7Dn45xRD |
4 |
|
E.I. du Pont de Nemours and Company submitted supplemental information regarding a retrospective exposure analysis of perfluorooctanoic acid (PFOA) intake over the past 53 years for residents in parts of Ohio and West Virginia, asserting that it does not trigger reporting obligations under TSCA 8(e) as it does not indicate substantial risk to health or the environment.
|
1900 |
AR226-3743
|
V35RNGrbLvXB9aqGMkzzV9e9w |
1 |
|
E.I. du Pont de Nemours and Company submitted supplemental information to the EPA regarding a retrospective exposure analysis of perfluorooctanoic acid (PFOA) intake over the past 53 years in Ohio and West Virginia, asserting that it does not trigger reporting obligations under TSCA 8(e) as it does not indicate substantial risk to health or the environment.
|
1900 |
AR226-3743
|
ymJeZkoX0r0Zd9g71JmrkbYRd |
1 |
|
E.I. du Pont de Nemours and Company submitted supplemental information regarding a retrospective exposure analysis of perfluorooctanoic acid (PFOA) intake over the past 53 years in Ohio and West Virginia, asserting that it does not trigger reporting obligations under TSCA 8(e) as it does not indicate substantial risk to health or the environment.
|
1900 |
AR226-3743
|
M5znXBMbk65vVYKM0MnD1YQk |
1 |